Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy
- PMID: 9328142
- PMCID: PMC2228056
- DOI: 10.1038/bjc.1997.474
Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy
Abstract
The NAD(P)H quinone oxidoreductase (NQO1:EC 1.6.99.2) is an important biotransformation enzyme system that is also known to metabolize important novel chemotherapeutic compounds. The gene that codes for this enzyme has recently been found to be polymorphic in humans. Here, we describe the ethnic distribution of the polymorphism and note that this may have implications for anti-tumour drug development and use.
Similar articles
-
NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.Clin Cancer Res. 2007 Mar 1;13(5):1584-90. doi: 10.1158/1078-0432.CCR-06-1416. Clin Cancer Res. 2007. PMID: 17332305
-
Quinone reductases multitasking in the metabolic world.Drug Metab Rev. 2004 Oct;36(3-4):639-54. doi: 10.1081/dmr-200033465. Drug Metab Rev. 2004. PMID: 15554240 Review.
-
An association between idiopathic Parkinson's disease and polymorphisms of phase II detoxification enzymes: glutathione S-transferase M1 and quinone oxidoreductase 1 and 2.Biochem Biophys Res Commun. 2001 Nov 9;288(4):887-92. doi: 10.1006/bbrc.2001.5868. Biochem Biophys Res Commun. 2001. PMID: 11688992
-
No associations between Parkinson's disease and polymorphisms of the quinone oxidoreductase (NQO1, NQO2) genes.Neurosci Lett. 2005 Mar 3;375(3):178-80. doi: 10.1016/j.neulet.2004.11.009. Epub 2004 Dec 10. Neurosci Lett. 2005. PMID: 15694256
-
Aerobic nitroreduction by flavoproteins: enzyme structure, mechanisms and role in cancer chemotherapy.Mini Rev Med Chem. 2001 Sep;1(3):293-306. doi: 10.2174/1389557013406800. Mini Rev Med Chem. 2001. PMID: 12369976 Review.
Cited by
-
CYP1A1, GSTM1, GSTT1 and NQO1 polymorphisms and colorectal adenomas in Japanese men.World J Gastroenterol. 2013 Jul 7;19(25):4023-30. doi: 10.3748/wjg.v19.i25.4023. World J Gastroenterol. 2013. PMID: 23840148 Free PMC article.
-
Effect of NQO1 and CYP4F2 genotypes on warfarin dose requirements in Hispanic-Americans and African-Americans.Pharmacogenomics. 2012 Dec;13(16):1925-35. doi: 10.2217/pgs.12.164. Pharmacogenomics. 2012. PMID: 23215885 Free PMC article.
-
NAD(P)H:quinone oxidoreductase 1 protects bladder epithelium against painful bladder syndrome in mice.Free Radic Biol Med. 2012 Nov 15;53(10):1886-93. doi: 10.1016/j.freeradbiomed.2012.08.584. Epub 2012 Aug 31. Free Radic Biol Med. 2012. PMID: 22985937 Free PMC article.
-
Roles of NAD(P)H:quinone Oxidoreductase 1 in Diverse Diseases.Life (Basel). 2021 Nov 26;11(12):1301. doi: 10.3390/life11121301. Life (Basel). 2021. PMID: 34947831 Free PMC article. Review.
-
NQO1 C609T polymorphism is associated with esophageal cancer risk among Chinese: a meta-analysis.Tumour Biol. 2014 Mar;35(3):2199-203. doi: 10.1007/s13277-013-1292-z. Epub 2013 Oct 19. Tumour Biol. 2014. PMID: 24142529
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous